❌

Reading view

Factor IX Padua AAV gene therapy in adolescents with hemophilia B: a phase 1 trial

Nature Medicine, Published online: 16 September 2026; doi:10.1038/s41591-026-04636-8

In this single-arm phase 1 trial, an AAV gene therapy carrying the Padua variant of factor IX was well tolerated in 11 adolescents with hemophilia B and led to reductions in annualized bleeding rate.
  •  

Recent progress in the rational design of mRNA vaccines

Jin and colleagues review recent advances in mRNA vaccines for infectious diseases and cancer, covering sequence optimization, circRNA/saRNA platforms, delivery systems, and clinical translation challenges, while highlighting the role of computational technologies.
  •  

VLA-Precision: Asymmetric Co-Bootstrapping for Efficient Real-World Online RL of Vision-Language-Action Models

arXiv:2609.04355v2 Announce Type: replace-cross Abstract: Pretrained vision-language-action (VLA) models enable broad manipulation but remain unreliable in tasks demanding precision and repeatability. Applying real-world online reinforcement learning (RL) to VLA post-training enables autonomous trial-and-error improvement beyond demonstrations alone, but exposes two bottlenecks: 1) unreliable value signals can induce policy drift; 2) large-VLA overhead constrains throughput and sample efficiency. To address these challenges, we present VLA-Precision, an efficient real-world online RL framework featuring the Asymmetric Co-Bootstrapping (ACoB) algorithm and the ACoB-Stream architecture. Specifically, ACoB establishes asymmetric co-bootstrapping across timescales: early intervention-guided behavioral learning rapidly improves policy performance while enhancing online experience quality. As autonomous experience accumulates, global return propagation and local preference ranking progressively calibrate value estimates, yielding relative action advantages for reference-regularized policy improvement while suppressing drift. To enable ACoB on large VLAs, we develop ACoB-Stream, a closed-loop experience--policy architecture that establishes invariant-state decoupling and on-demand streaming as design principles, delivering up to 10.9$\times$ improvements in throughput and computational efficiency. Extensive evaluations on nine high-precision chemistry tasks across four categories and four robot embodiments show that VLA-Precision achieves 98.3\% mean success rate in 45.8 min/task, with 27.6 s episodes running at 1.2$\times$ and 1.8$\times$ the speeds of VLA and RL baselines. Resources are available at https://vla-precision.github.io.
  •  

Imaging interface-controlled bulk oxygen spillover

Nature, Published online: 15 April 2026; doi:10.1038/s41586-026-10324-x

In situ microscopic single-particle imaging demonstrates the significance of rationally engineered metal–support interfaces for activating the oxygen in bulk catalyst, helping elucidate reaction pathways in catalytic conversions.
  •  

Lysine attenuates acute lung injury by restoring α-tubulin acetylation and ciliary activity

Cell Death Discovery, Published online: 16 March 2026; doi:10.1038/s41420-026-03025-x

Lysine attenuates acute lung injury by restoring α-tubulin acetylation and ciliary activity
  •  

Unraveling the role of cuproptosis in pulmonary fibrosis pathogenesis and prognosis: an integrative single-cell transcriptomics and microarray analysis

Mol Cell Biochem. 2026 Mar 13. doi: 10.1007/s11010-026-05510-4. Online ahead of print.

ABSTRACT

Pulmonary fibrosis (PF), a progressive interstitial lung disease with elusive pathogenesis, remains a therapeutic challenge. Emerging evidence suggests cuproptosis-a copper-dependent cell death pathway-may play a regulatory role in disease progression. This study aims to elucidate cuproptosis's biological function and establish a prognostic model for PF. Through integrative analysis of single-cell RNA-seq data from bleomycin (BLM)-induced mouse models and bulk RNA-seq data from idiopathic pulmonary fibrosis (IPF) patients, we identified cuproptosis-related genes (CRGs) using LASSO regression and Cox regression. A novel 4-CRG signature (LIAS, LIPT1, ATP7A, PDHB) was constructed to stratify patients into distinct risk groups in the GSE70866 cohort, where high-risk individuals exhibited poorer survival and enhanced extracellular matrix/lipid metabolism activity via GO/KEGG analysis. Experimental validation in BLM-induced mouse models, TGF-β1-stimulated fibroblast-to-myofibroblast transition assays, and human IPF specimens demonstrated significant downregulation of CRGs through qRT-PCR and immunohistochemical analyses. Functional assays revealed impaired cell viability and elevated cuproptosis markers in fibrotic microenvironments. Our findings establish an inverse correlation between cuproptosis and PF progression, and propose a robust risk-score model for clinical prognosis prediction. This multi-omics approach provides new insights into copper-mediated regulatory mechanisms in fibrogenesis.

PMID:41824199 | DOI:10.1007/s11010-026-05510-4

  •  

Performance of Conventional EEG Biomarkers Across Different Clinical Phases of Major Depressive Disorder: A Comprehensive Evaluation

arXiv:2603.03864v1 Announce Type: new Abstract: While EEG features differentiate Major Depressive Disorder (MDD) from healthy controls (HC), their clinical utility as biomarkers depends on a monotonic trajectory across the disease spectrum, from the acute (AC) phase to the maintenance (MA) phase and finally to the healthy baseline. However, the progression of the MA phase remains poorly understood in traditional marker analysis. Analyzing EEG data from 74 individuals (24 AC, 23 MA, and 27 HC), this study provides a comprehensive evaluation of classic ERP and resting-state indices across AC, MA, and HC groups. Our results demonstrate that almost no conventional metrics strictly satisfy the criterion of monotonic progression, likely due to profound inter-individual heterogeneity. These findings highlight the inherent limitations of group-level feature extraction and provide critical insights for developing future paradigms and algorithms to identify neurobiological markers with genuine clinical utility.
  •  

CRCC: Contrast-Based Robust Cross-Subject and Cross-Site Representation Learning for EEG

arXiv:2602.19138v1 Announce Type: new Abstract: EEG-based neural decoding models often fail to generalize across acquisition sites due to structured, site-dependent biases implicitly exploited during training. We reformulate cross-site clinical EEG learning as a bias-factorized generalization problem, in which domain shifts arise from multiple interacting sources. We identify three fundamental bias factors and propose a general training framework that mitigates their influence through data standardization and representation-level constraints. We construct a standardized multi-site EEG benchmark for Major Depressive Disorder and introduce CRCC, a two-stage training paradigm combining encoder-decoder pretraining with joint fine-tuning via cross-subject/site contrastive learning and site-adversarial optimization. CRCC consistently outperforms state-of-the-art baselines and achieves a 10.7 percentage-point improvement in balanced accuracy under strict zero-shot site transfer, demonstrating robust generalization to unseen environments.
  •  
❌